![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 45, 41803-41809, November 9, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
c*
§,
§, and
From the Box1 and 2 (box1/2) are conserved cytoplasmic
motifs located in the membrane proximal region of cytokine receptors,
including the human granulocyte-macrophage colony-stimulating
factor (GM-CSF) receptor common
Department of Molecular and Developmental
Biology, Institute of Medical Science, § Core Research for
Evolutional Science and Technology, Japan Science and Technology
Corporation, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo
108-8639, Japan, and the ¶ Biomolecular Characterization Division,
RIKEN (Institute of Physical and Chemical Research), 2-1, Hirosawa,
Wako-shi, Saitama 351-0198, Japan
c. Deletion of box1/2 abrogated all
the examined activities of GM-CSF, and this phenomenon is explained by
the loss of binding by Jak2. To test if a molecule other than Jak2 interacting with the box1/2 region plays a role in GM-CSF receptor signal transduction, we screened for molecules interacting with the
box1/2 region by a pull-down assay using recombinant purified protein
of GST fused with the
c box1/2 region and a Ba/F3 cell lysate. The
mouse homologue of Mad2 protein, which plays an important role in the M
phase of the cell cycle, was revealed to associate with the box1/2
region specifically. Peptides corresponding to the box1
sequence also bound to Mad2, and mutation of the box1 decreased the Mad2 interaction. Deletion analysis indicated that interaction with box1/2 occurred through the C-terminal portion of
Mad2. Mad2 is known to change affinity for binding partners cell cycle
dependently. Binding affinity of Mad2 to box1/2 increased in the late M
phase, suggesting the possibility that GM-CSF participates in
regulation of the M phase check point through interaction with Mad2.
To whom correspondence should be addressed: Dept. of
Molecular and Developmental Biology, Inst. of Medical Science,
University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Tel.: 81-3-5449-5660; Fax: 81-3-5449-5424; E-mail:
sumiko@ims.u-tokyo.ac.jp.
This article has been cited by other articles:
![]() |
S. Ito, C. R. Mantel, M.-K. Han, S. Basu, S. Fukuda, S. Cooper, and H. E. Broxmeyer Mad2 is required for optimal hematopoiesis: Mad2 associates with c-Kit in MO7e cells Blood, March 1, 2007; 109(5): 1923 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Aoki, N. Suzui, S. Fujimaki, N. Dohmae, K. Yonekura-Sakakibara, T. Fujiwara, H. Hayashi, T. Yamaya, and H. Sakakibara Destination-Selective Long-Distance Movement of Phloem Proteins PLANT CELL, June 1, 2005; 17(6): 1801 - 1814. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pati, B. R. Haddad, A. Haegele, H. Thompson, F. S. Kittrell, A. Shepard, C. Montagna, N. Zhang, G. Ge, S. K. Otta, et al. Hormone-Induced Chromosomal Instability in p53-Null Mammary Epithelium Cancer Res., August 15, 2004; 64(16): 5608 - 5616. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Umezu-Goto, Y. Kishi, A. Taira, K. Hama, N. Dohmae, K. Takio, T. Yamori, G. B. Mills, K. Inoue, J. Aoki, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production J. Cell Biol., July 22, 2002; 158(2): 227 - 233. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |